InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2021 Results, Operational Highlights
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has reported its financial results for second quarter 2021; the company also released a corporate and commercial update. Highlights of the report included total revenue of $5.3 million, which represents a 46% increase sequentially and a 194% year over year, a validated B2B expansion with new clients being secured in all B2B segments; patients…